Organogenesis Holdings (FRA:2PQ) YoY EBITDA Growth : -173.91% (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Organogenesis Holdings YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Organogenesis Holdings's YoY EBITDA Growth for the quarter that ended in Jun. 2024 was -173.91%.

Organogenesis Holdings's EBITDA per Share for the three months ended in Jun. 2024 was €-0.07.

Organogenesis Holdings YoY EBITDA Growth Historical Data

The historical data trend for Organogenesis Holdings's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organogenesis Holdings YoY EBITDA Growth Chart

Organogenesis Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

67.95

243.98

109.45

-50.00

-13.54

Organogenesis Holdings Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
YoY EBITDA Growth	Get a 7-Day Free Trial															-12.38	144.12	-43.28	-	-173.91

Organogenesis Holdings YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Organogenesis Holdings's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(0.249	-	0.288)	/	\| 0.288 \|
=	-13.54 %

Organogenesis Holdings's YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

	YoY EBITDA Growth (Q: Jun. 2024 )
=	(EBITDA per Share (Q: Jun. 2024 )	-	EBITDA per Share (Q: Jun. 2023 ))	/	\| EBITDA per Share (Q: Jun. 2023 )) \|
=	(-0.068	-	0.092)	/	\| 0.092 \|
=	-173.91 %

Organogenesis Holdings YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Organogenesis Holdings's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Organogenesis Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organogenesis Holdings Inc (FRA:2PQ) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

ORGO:USA

Address

85 Dan Road, Canton, MA, USA, 02021

Website

https://www.organogenesis.com

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.

Organogenesis Holdings Headlines

No Headlines